<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36271419</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Dehydration is associated with production of organic osmolytes and predicts physical long-term symptoms after COVID-19: a multicenter cohort study.</ArticleTitle><Pagination><StartPage>322</StartPage><MedlinePgn>322</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">322</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-022-04203-w</ELocationID><Abstract><AbstractText Label="BACKGROUND">We have previously shown that iatrogenic dehydration is associated with a shift to organic osmolyte production in the general ICU population. The aim of the present investigation was to determine the validity of the physiological response to dehydration known as aestivation and its relevance for long-term disease outcome in COVID-19.</AbstractText><AbstractText Label="METHODS">The study includes 374 COVID-19 patients from the Pronmed cohort admitted to the ICU at Uppsala University Hospital. Dehydration data was available for 165 of these patients and used for the primary analysis. Validation was performed in Biobanque Qu&#xe9;b&#xe9;coise de la COVID-19 (BQC19) using 1052 patients with dehydration data. Dehydration was assessed through estimated osmolality (eOSM&#x2009;=&#x2009;2Na&#x2009;+&#x2009;2&#xa0;K&#x2009;+&#x2009;glucose&#x2009;+&#x2009;urea), and correlated to important endpoints including death, invasive mechanical ventilation, acute kidney injury, and long COVID-19 symptom score grouped by physical or mental.</AbstractText><AbstractText Label="RESULTS">Increasing eOSM was correlated with increasing role of organic osmolytes for eOSM, while the proportion of sodium and potassium of eOSM were inversely correlated to eOSM. Acute outcomes were associated with pronounced dehydration, and physical long-COVID was more strongly associated with dehydration than mental long-COVID after adjustment for age, sex, and disease severity. Metabolomic analysis showed enrichment of amino acids among metabolites that showed an aestivating pattern.</AbstractText><AbstractText Label="CONCLUSIONS">Dehydration during acute COVID-19 infection causes an aestivation response that is associated with protein degradation and physical long-COVID.</AbstractText><AbstractText Label="TRIAL REGISTRATION">The study was registered &#xe0; priori (clinicaltrials.gov: NCT04316884 registered on 2020-03-13 and NCT04474249 registered on 2020-06-29).</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hultstr&#xf6;m</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Akademiska Sjukhuset, ANOPIVA, Ing70, 2Tr, 75185, Uppsala, Sweden. michael.hultstrom@mcb.uu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. michael.hultstrom@mcb.uu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada. michael.hultstrom@mcb.uu.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada. michael.hultstrom@mcb.uu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipcsey</LastName><ForeName>Miklos</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Akademiska Sjukhuset, ANOPIVA, Ing70, 2Tr, 75185, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hedenstierna Laboratory, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Dave R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakanishi</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyoto-McGill International Collaborative Program in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Japan Society for the Promotion of Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler-Laporte</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yiheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshiji</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyoto-McGill International Collaborative Program in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Japan Society for the Promotion of Science, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forgetta</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 Prime Sciences, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farjoun</LastName><ForeName>Yossi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 Prime Sciences, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Broad Institute of Harvard and MIT, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fulcrum Genomics, Bolder, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallin</LastName><ForeName>Ewa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Akademiska Sjukhuset, ANOPIVA, Ing70, 2Tr, 75185, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>Ing-Marie</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Akademiska Sjukhuset, ANOPIVA, Ing70, 2Tr, 75185, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Chemistry, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marton</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Program in Cardiovascular and Metabolic Disorders, Duke- NUS Medical School, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Titze</LastName><ForeName>Jens Marc</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Program in Cardiovascular and Metabolic Disorders, Duke- NUS Medical School, Singapore, Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nihl&#xe9;n</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Akademiska Sjukhuset, ANOPIVA, Ing70, 2Tr, 75185, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>J Brent</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, McGill University, Montreal, QC, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Twin Research, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 Prime Sciences, Montreal, QC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frithiof</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Akademiska Sjukhuset, ANOPIVA, Ing70, 2Tr, 75185, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04316884</AccessionNumber><AccessionNumber>NCT04474249</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>KAW 2020.0182</GrantID><Agency>Knut och Alice Wallenbergs Stiftelse</Agency><Country/></Grant><Grant><GrantID>20210089, 20190639, 20190637</GrantID><Agency>Hj&#xe4;rt-Lungfonden</Agency><Country/></Grant><Grant><GrantID>SLS-938101</GrantID><Agency>Svenska L&#xe4;kares&#xe4;llskapet</Agency><Country/></Grant><Grant><GrantID>CIHR: 365825</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant><Grant><GrantID>2014-02569, 2014-07606</GrantID><Agency>Vetenskapsr&#xe5;det</Agency><Country/></Grant><Grant><GrantID>F2020-0054</GrantID><Agency>Swedish Kidney Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9NEZ333N27</RegistryNumber><NameOfSubstance UI="D012964">Sodium</NameOfSubstance></Chemical><Chemical><RegistryNumber>8W8T17847W</RegistryNumber><NameOfSubstance UI="D014508">Urea</NameOfSubstance></Chemical><Chemical><RegistryNumber>RWP5GA015D</RegistryNumber><NameOfSubstance UI="D011188">Potassium</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003681" MajorTopicYN="N">Dehydration</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012964" MajorTopicYN="N">Sodium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014508" MajorTopicYN="N">Urea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011188" MajorTopicYN="N">Potassium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Aestivation</Keyword><Keyword MajorTopicYN="N">Intensive care medicine</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Urea synthesis</Keyword></KeywordList><CoiStatement>JBR served as an advisor to GlaxoSmithKline and Deerfield Capital, and is the founder and CEO of 5 Prime Sciences. VF and YF are employed by 5 Prime Sciences. YF consults for Fulcrum Genomics. The other authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36271419</ArticleId><ArticleId IdType="pmc">PMC9585783</ArticleId><ArticleId IdType="doi">10.1186/s13054-022-04203-w</ArticleId><ArticleId IdType="pii">10.1186/s13054-022-04203-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hultstrom M, von Seth M, Frithiof R. Hyperreninemia and low total body water may contribute to acute kidney injury in COVID-19 patients in intensive care. J Hypertens. 2020;38(8):1613&#x2013;1614. doi: 10.1097/HJH.0000000000002531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000002531</ArticleId><ArticleId IdType="pmc">PMC7282406</ArticleId><ArticleId IdType="pubmed">32472780</ArticleId></ArticleIdList></Reference><Reference><Citation>Luther T, Bulow-Anderberg S, Larsson A, Rubertsson S, Lipcsey M, Frithiof R, Hultstrom M. COVID-19 patients in intensive care develop predominantly oliguric acute kidney injury. Acta Anaesthesiol Scand. 2021;65(3):364&#x2013;372. doi: 10.1111/aas.13746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13746</ArticleId><ArticleId IdType="pmc">PMC7753792</ArticleId><ArticleId IdType="pubmed">33190222</ArticleId></ArticleIdList></Reference><Reference><Citation>Stookey JD, Allu PKR, Chabas D, Pearce D, Lang F. Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19. Med Hypotheses. 2020;144:110237. doi: 10.1016/j.mehy.2020.110237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110237</ArticleId><ArticleId IdType="pmc">PMC7467030</ArticleId><ArticleId IdType="pubmed">33254543</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihlen S, Frithiof R, Titze J, Kawati R, Rasmusson J, Rylander C, Pikwer A, Castegren M, Belin A, Hultstrom M, et al. The contribution of plasma urea to total osmolality during iatrogenic fluid reduction in critically ill patients. Function (Oxf) 2022;3(1):zqab055. doi: 10.1093/function/zqab055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/function/zqab055</ArticleId><ArticleId IdType="pmc">PMC8788870</ArticleId><ArticleId IdType="pubmed">35330925</ArticleId></ArticleIdList></Reference><Reference><Citation>Delles C, Rossitto G. Of snails, earthworms, and men: insights into strategies to preserve water. Function (Oxf) 2022;3(1):zqab071. doi: 10.1093/function/zqab071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/function/zqab071</ArticleId><ArticleId IdType="pmc">PMC8788808</ArticleId><ArticleId IdType="pubmed">35330922</ArticleId></ArticleIdList></Reference><Reference><Citation>Haussinger D, Lang F, Gerok W. Regulation of cell function by the cellular hydration state. Am J Physiol. 1994;267(3 Pt 1):E343&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">7943214</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild J, Jung R, Knopp T, Efentakis P, Benaki D, Grill A, Wegner J, Molitor M, Garlapati V, Rakova N, et al. Aestivation motifs explain hypertension and muscle mass loss in mice with psoriatic skin barrier defect. Acta Physiol (Oxf) 2021;232:e13628. doi: 10.1111/apha.13628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.13628</ArticleId><ArticleId IdType="pubmed">33590724</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada K, Daub S, Zhang Y, Klein JD, Nakano D, Pedchenko T, Lantier L, LaRocque LM, Marton A, Neubert P, et al. High salt intake reprioritizes osmolyte and energy metabolism for body fluid conservation. J Clin Invest. 2017;127(5):1944&#x2013;1959. doi: 10.1172/JCI88532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI88532</ArticleId><ArticleId IdType="pmc">PMC5409074</ArticleId><ArticleId IdType="pubmed">28414295</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik J, Morisawa N, Wild J, Marton A, Takase-Minegishi K, Minegishi S, Daub S, Sands JM, Klein JD, Bailey JL, et al. Adaptive physiological water conservation explains hypertension and muscle catabolism in experimental chronic renal failure. Acta Physiol (Oxf) 2021;232:e13629. doi: 10.1111/apha.13629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.13629</ArticleId><ArticleId IdType="pmc">PMC8244025</ArticleId><ArticleId IdType="pubmed">33590667</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirabella S, Gomez-Paz S, Lam E, Gonzalez-Mosquera L, Fogel J, Rubinstein S. Glucose dysregulation and its association with COVID-19 mortality and hospital length of stay. Diabetes Metab Syndr. 2022;16(3):102439. doi: 10.1016/j.dsx.2022.102439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2022.102439</ArticleId><ArticleId IdType="pmc">PMC8867960</ArticleId><ArticleId IdType="pubmed">35255293</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) Intensive Care Med. 2020;46(5):854&#x2013;887. doi: 10.1007/s00134-020-06022-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06022-5</ArticleId><ArticleId IdType="pmc">PMC7101866</ArticleId><ArticleId IdType="pubmed">32222812</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno RP, Metnitz PG, Almeida E, Jordan B, Bauer P, Campos RA, Iapichino G, Edbrooke D, Capuzzo M, Le Gall JR, et al. SAPS 3&#x2014;From evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005;31(10):1345&#x2013;1355. doi: 10.1007/s00134-005-2763-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2763-5</ArticleId><ArticleId IdType="pmc">PMC1315315</ArticleId><ArticleId IdType="pubmed">16132892</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>